Peter C. Gareiss

2.8k citations
26 papers · 2.2k · 1 hit paper · h-index 17

Impact in

    • Protein Degradation and Inhibitors
    • Ubiquitin and proteasome pathways
    • RNA and protein synthesis mechanisms
    • RNA Research and Splicing
    • RNA modifications and cancer
    • Microbial Natural Products and Biosynthesis

Papers in

    • RNA and protein synthesis mechanisms 6
    • Chemical Synthesis and Analysis 5
    • Ubiquitin and proteasome pathways 4
    • Protein Degradation and Inhibitors 3
    • Click Chemistry and Applications 3
    • Synthesis and Catalytic Reactions 3

Peter C. Gareiss

25 papers receiving 2.1k citations

Peter C. Gareiss's Hit Papers

An analysis of FDA-approved drugs: natural products and their derivatives 2015 · 610 citations
6100+3+7Years since publication200400600

Peers

Peter C. Gareiss
Comparison fields: 5 of 112
  • Molecular Biology 1.7k
  • Pharmacology 255
  • Hematology 156
  • Oncology 324
  • Organic Chemistry 328
Replace Anne Cleasby with:
Anne Cleasby United Kingdom
Marina Ignatushchenko United States
Mohane Selvaraj Coumar India
Yung-Chi Cheng United States
Matthias Wirth Germany
Adam Yasgar United States
James M. Woolven United Kingdom
Athanasios Papakyriakou Greece
Manlio Tolomeo Italy
Georgina A. Holloway Australia
Peter C. Gareiss relative to Anne Cleasby United Kingdom Anne Cleasby's profile →
Citations per field
00.5×2.7×
Anne Cleasby · 1×
Citations per year

Countries citing papers authored by Peter C. Gareiss

Since Specialization
Citations

This map shows the geographic impact of Peter C. Gareiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Gareiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Gareiss more than expected).

Fields of papers citing papers by Peter C. Gareiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Gareiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Gareiss. The network helps show where Peter C. Gareiss may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter C. Gareiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter C. Gareiss Line = papers co-authored together Peter C. Gareiss links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An analysis of FDA-approved drugs: natural products and their derivatives
Hit paper breakdown →
2015610
2 2012402
3 2012230
4 2008150
5 2014111
6 2015111
7 200685
8 200779
9 201664
10 201663
11 200838
12 201531
13 202429
14 201029
15 200923
16 202019
17
Ribosomal frameshifting: an emerging drug target for HIV.
200919
18 201015
19 201214
20 200912

About Peter C. Gareiss

Peter C. Gareiss is a scholar working on Molecular Biology, Organic Chemistry, Cancer Research, Pharmacology and Oncology, having authored 26 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (6 papers), Chemical Synthesis and Analysis (5 papers), Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Click Chemistry and Applications (3 papers), Synthesis and Catalytic Reactions (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Pharmacology (255 citations), Hematology (156 citations), Oncology (324 citations) and Organic Chemistry (328 citations). Peter C. Gareiss has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include Daniël Hoyer, Eric Patridge, Michael S. Kinch, Benjamin L. Miller, Craig M. Crews, Hyun Seop Tae, Dennis L. Buckley, Inge Van Molle, Alessio Ciulli and William L. Jorgensen. Their work appears in journals such as Journal of the American Chemical Society, ACS Chemical Biology, Drug Discovery Today, Biochemistry and Nature Structural & Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact